---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-015346"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2026-01-16T23:59:59+00:00"
generated_at: "2026-05-16T09:42:48.670736+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics prices $15M public offering of 39.5M units at $0.38; net ~$13.3M

## Summary
- Offering of 39,473,684 units at $0.38 each, each unit = one share + one warrant.
- Gross proceeds $15M; net proceeds ~$13.3M after underwriting discounts and expenses.
- Underwriter exercised over-allotment for additional 5,921,052 warrants.
- Warrants immediately exercisable at $0.38 per share, expire in 5 years.
- Proceeds for working capital; 45-day insiders lock-up and 120-day ban on variable rate transactions.

## SEC filing metadata
- accession: 0001193125-26-015346
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2026-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312526015346/0001193125-26-015346-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312526015346/d65677d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-015346
- JSON: https://secwatch.observer/filing/0001193125-26-015346.json
- Plain text: https://secwatch.observer/filing/0001193125-26-015346.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.